ArticleInternational journal of clinical oncology2024

Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan.

Akihiro Yoshimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.